Beckman Coulter Inc - Company Profile
Powered by 
All the sales intelligence you need on Beckman Coulter Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Beckman Coulter Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Beckman Coulter Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Beckman Coulter Inc (Beckman), a subsidiary of Danaher Corp, manufactures biomedical testing instrument systems. The company develops, manufactures, and markets biomedical laboratory instruments, software, and other things that simplify and automate complex biomedical tests. Its comprehensive diagnostic tests, instruments, and business management services help healthcare professionals in hospitals, laboratories, and other critical care settings globally to assess, diagnose, and monitor conditions ranging from cardiac diseases to blood disorders, metabolic functions, infectious diseases, and cancer, among others. The company also provides scientific solutions for laboratory customers such as universities, biotechnology and pharmaceutical companies, governments, hospitals, and commercial laboratories. It operates across the US, Europe, Canada, and Asia with clinical and research systems operating in laboratories worldwide. Beckman is headquartered in Brea, California, the US.
Headquarters
United States of America
Address
250 South Kraemer Boulevard, Brea, California, 92821-6232
Website
www.beckmancoulter.com
Telephone
1 714 9935321
No of Employees
11,000
Industry
Medical Equipment
Beckman Coulter Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| Pre- and Post- Analytical Automation Solutions: | Airfuge |
| Sample Processing Systems | Allegra |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | New Products/Services | In April, Beckman Coulter Life Sciences launched the OptiMATE Gradient Maker. |
| 2025 | Regulatory Approval | In January, the company received the FDA's Breakthrough Device Designation for its Alzheimer's Disease Blood Test known as Access p‑Tau217/β-Amyloid 1-42 plasma ratio. |
| 2025 | Research and Development | In January, the company introduced a new research use only (RUO) blood-based biomarker immunoassays designed to advance neurodegenerative disease research. |
Competitor Comparison
| Key Parameters | Beckman Coulter Inc | Agilent Technologies Inc | Sysmex Corp | Revvity Inc | Cytek Biosciences Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Japan | United States of America | United States of America |
| City | Brea | Santa Clara | Kobe | Waltham | Fremont |
| State/Province | California | California | Hyogo | Massachusetts | California |
| No. of Employees | 11,000 | 17,900 | 11,457 | 11,000 | 678 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Tom Coffman | Chief Financial Officer; Senior Vice President | Senior Management | - | - |
| Tom Neufelder | Chief Technology Officer | Senior Management | - | - |
| Kevin O'Reilly | President - Beckman Coulter Diagnostics | Senior Management | 2024 | - |
| Mike Rembelski | Vice President - Global Services | Senior Management | 2019 | - |
| Joseph Gottfried, MD, JD | Vice President - Strategy | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer